You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 25, 2025

Details for Patent: 10,695,354


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,695,354 protect, and when does it expire?

Patent 10,695,354 protects APTIOM and is included in one NDA.

This patent has seven patent family members in six countries.

Summary for Patent: 10,695,354
Title:Methods of treatment of partial onset seizures using eslicarbazepine acetate
Abstract: The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
Inventor(s): de Almeida; Jose Luis (Arouca, PT), Soares da Silva; Patricio Manuel Vieira Ara (Oporto, PT)
Assignee: Bial-Portela & CA S.A. (Sao Mamede do Coronado, PT)
Application Number:16/449,057
Patent Claim Types:
see list of patent claims
Use; Delivery; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using USPTO Resources

Introduction

When analyzing the scope and claims of a U.S. patent, such as United States Patent 10,695,354, it is crucial to understand the various tools and resources available through the United States Patent and Trademark Office (USPTO) and other international patent offices. This guide will walk you through the steps and resources necessary to conduct a comprehensive analysis.

Understanding Patent Scope and Claims

Patent scope is a critical aspect of patent quality, often debated in terms of breadth, clarity, and validity. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Tools for Patent Searching

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art. It offers two modern interfaces that enhance access to patent information, replacing legacy tools like PubEast and PubWest[1].

Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications from participating IP Offices. This includes access to file histories, classification, citation data, and office action indicators[1].

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, provides access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources. They are invaluable for those new to patent searching[1].

Searching for Specific Patents

Electronic Official Gazette

The Electronic Official Gazette allows users to browse issued patents for the current week, categorized by classification or type of patent (utility, design, plant)[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP5 Offices, providing a single point of access to prior art cited for a patent application family[1].

Analyzing Patent 10,695,354

Retrieving the Patent Document

To analyze the scope and claims of US Patent 10,695,354, start by retrieving the patent document using the Patent Public Search tool or the Electronic Official Gazette.

Understanding Claim Language

Examine the independent claim length and count, as these metrics can provide insights into the patent's scope. Research suggests that these metrics have explanatory power for several correlates of patent scope, such as patent maintenance payments and forward citations[3].

Reviewing Patent Claims

Carefully review the claims section of the patent to understand the specific inventions or innovations covered. Claims define the legal boundaries of the invention and are crucial for determining the patent's scope.

Examining Prior Art and Citations

Use the Common Citation Document (CCD) to see the prior art cited by various offices for the patent family. This helps in understanding how the patent fits into the broader patent landscape[1].

International Patent Landscape

If the patent has international counterparts, use resources like the European Patent Office's esp@cenet, the Japan Patent Office's database, or WIPO's PATENTSCOPE to analyze the global patent family and related applications[1][4].

Additional Resources for In-Depth Analysis

Cooperative Patent Classification (CPC)

The CPC database can be searched to find relevant classification schemes, helping to identify similar patents and understand the broader technological context[4].

Patent Examination Data System (PEDS)

The PEDS allows users to search, view, and download bibliographic data for publicly available patent applications. This can provide insights into the examination process and any office actions related to the patent[1].

Sequence Listings

For patents involving sequences, the Publication Site for Issued and Published Sequences (PSIPS) provides access to sequence listings and other mega items[1].

Practical Steps for Analysis

Step 1: Retrieve the Patent

Use the Patent Public Search tool to retrieve the full text of US Patent 10,695,354.

Step 2: Analyze Claims

Examine the claims section to understand the specific inventions covered. Note the independent claim length and count.

Step 3: Review Prior Art

Use the CCD to consolidate citation data from participating offices.

Step 4: Examine International Counterparts

Search international databases to understand the global patent landscape.

Step 5: Use Classification Tools

Utilize the CPC database to find relevant classification schemes.

Expert Insights and Statistics

Metrics for Patent Scope

Research indicates that narrower claims are associated with a higher probability of grant and shorter examination processes. For example, a study found that independent claim length and count have explanatory power for several correlates of patent scope[3].

International Cooperation

The global patent system is increasingly integrated, with tools like the Global Dossier and CCD facilitating international cooperation and harmonization[1].

Key Takeaways

  • Use Advanced Search Tools: Utilize the USPTO's Patent Public Search, Global Dossier, and CCD to gather comprehensive information.
  • Analyze Claim Language: Independent claim length and count are crucial metrics for understanding patent scope.
  • Examine Prior Art: Consolidate citation data using the CCD to understand the broader patent landscape.
  • Consider International Context: Search international databases to understand the global implications of the patent.
  • Leverage Classification Tools: Use the CPC database to identify relevant technological contexts.

FAQs

Q: How do I retrieve a specific U.S. patent document?

A: You can retrieve a specific U.S. patent document using the USPTO's Patent Public Search tool or the Electronic Official Gazette.

Q: What is the significance of independent claim length and count in patent scope analysis?

A: Independent claim length and count are metrics that provide insights into the breadth and clarity of a patent, with narrower claims often associated with a higher probability of grant and shorter examination processes[3].

Q: How can I find prior art cited for a patent application family?

A: Use the Common Citation Document (CCD) application to consolidate citation data from participating IP5 Offices[1].

Q: What resources are available for searching international patent databases?

A: Resources include the European Patent Office's esp@cenet, the Japan Patent Office's database, WIPO's PATENTSCOPE, and others[1][4].

Q: Where can I find training and assistance for patent searching?

A: The USPTO's Public Search Facility and local Patent and Trademark Resource Centers (PTRCs) offer training and assistance for patent searching[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Clemson University - Advanced Patent Searching: https://clemson.libguides.com/advanced_patent_searching
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,695,354

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-001 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF PARTIAL-ONSET SEIZURES IN A PATIENT WITH REFRACTORY PARTIAL-ONSET SEIZURES ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-001 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF PARTIAL-ONSET SEIZURES ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-002 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF PARTIAL-ONSET SEIZURES ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-002 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF PARTIAL-ONSET SEIZURES IN A PATIENT WITH REFRACTORY PARTIAL-ONSET SEIZURES ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-003 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF PARTIAL-ONSET SEIZURES IN A PATIENT WITH REFRACTORY PARTIAL-ONSET SEIZURES ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-003 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF PARTIAL-ONSET SEIZURES ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-004 Nov 8, 2013 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF PARTIAL-ONSET SEIZURES IN A PATIENT WITH REFRACTORY PARTIAL-ONSET SEIZURES ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,695,354

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 055939 ⤷  Try for Free
Australia 2005331690 ⤷  Try for Free
Brazil PI0520258 ⤷  Try for Free
Canada 2607427 ⤷  Try for Free
Mexico 2007013882 ⤷  Try for Free
Mexico 366496 ⤷  Try for Free
World Intellectual Property Organization (WIPO) 2006120501 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.